Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

BACKGROUND: External beam radiotherapy (EBRT) is the treatment of choice for irresectable meningioma. Due to the strong expression of somatostatin receptors, peptide receptor radionuclide therapy (PRRT) has been used in advanced cases. We assessed the feasibility and tolerability of a combination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreissl, Michael C, Hänscheid, Heribert, Löhr, Mario, Verburg, Frederik A, Schiller, Markus, Lassmann, Michael, Reiners, Christoph, Samnick, Samuel S, Buck, Andreas K, Flentje, Michael, Sweeney, Reinhart A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439242/
https://www.ncbi.nlm.nih.gov/pubmed/22720902
http://dx.doi.org/10.1186/1748-717X-7-99

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439242/
https://www.ncbi.nlm.nih.gov/pubmed/22720902
http://dx.doi.org/10.1186/1748-717X-7-99

Ejemplares similares